Valsartan API impurity Leads to Recall of Some Products
Very seldom do we see a notice of recall that relates to a change in the manufacture or processing of the Active Pharmaceutical Ingredient (API), but that is what appears to have happened in this instance. The FDA announcement states: The U.S. Food and Drug Administration is alerting health care professionals and patients of a […]